Prognostic Value and Potential Regulatory Mechanism of H19 in Stomach Adenocarcinoma

Overview

Journal J Oncol

Specialty Oncology

Date 2022 Sep 12

PMID 36090894

Authors

Hongyuan Guo

Xu Guo

Yuanyuan Su

Minghui Liu

Xi Chen

Hao Zhu

Zheng Fu

Affiliations

Soon will be listed here.

Abstract

The first lncRNA discovered, H19, has been found to participate in the regulation of diverse biological processes, including the pathogenesis of stomach adenocarcinoma. In addition to its oncogenic function in tumor formation, a high level of H19 in tumor tissues has also been reported to be an indicator for poor prognosis. However, although many previous works have investigated the level of H19 as an independent indicator for prognosis, the real value of H19 in predicting survival has rarely been evaluated. In this study, we established a prognostic model and nomogram for stomach adenocarcinoma by combining the expression level of H19 with traditional indices, which showed the value of H19 in predicting the survival rates of patients. In addition, we investigated the mechanism underlying the correlation of the H19 level in cancer tissue with poor prognosis in patients. Our results showed that H19 could function as ceRNA by sponging five miRNAs, which may promote the progression of cancer.

References

Sun K, Lv H, Chen B, Nie C, Zhao J, Wang S . Dawning precision treatment for gastric cancer: The latest biomarkers. J Transl Int Med. 2022; 9(4):228-230. PMC: 8802398. DOI: 10.2478/jtim-2021-0023. View

Shen H, Wang L, Chen Q, Xu J, Zhang J, Fang L . The prognostic value of COL3A1/FBN1/COL5A2/SPARC-mir-29a-3p-H19 associated ceRNA network in Gastric Cancer through bioinformatic exploration. J Cancer. 2020; 11(17):4933-4946. PMC: 7378928. DOI: 10.7150/jca.45378. View

Dicken B, Bigam D, Cass C, Mackey J, Joy A, Hamilton S . Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2004; 241(1):27-39. PMC: 1356843. DOI: 10.1097/01.sla.0000149300.28588.23. View

Song P, Jiang B, Liu Z, Ding J, Liu S, Guan W . A three-lncRNA expression signature associated with the prognosis of gastric cancer patients. Cancer Med. 2017; 6(6):1154-1164. PMC: 5463065. DOI: 10.1002/cam4.1047. View

Wang W, Yang Q, Huang Q, Zhang H, Zhang Z, Gao J . The rs2839698 Single Nucleotide Polymorphism of lncRNA H19 is Associated with Post-Operative Prognosis in T3 Gastric Adenocarcinoma. Clin Lab. 2018; 64(1):105-112. DOI: 10.7754/Clin.Lab.2017.170706. View

Wu M, Wang H, Lin C, Sheu J, Shun C, Lee W . Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma. Cancer Lett. 1998; 120(1):9-14. DOI: 10.1016/s0304-3835(97)00279-6. View

Wang Y, Hou K, Jin Y, Bao B, Tang S, Qi J . Lung adenocarcinoma-specific three-integrin signature contributes to poor outcomes by metastasis and immune escape pathways. J Transl Int Med. 2022; 9(4):249-263. PMC: 8802404. DOI: 10.2478/jtim-2021-0046. View

Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K . Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008; 18(10):997-1006. DOI: 10.1038/cr.2008.282. View

McGeary S, Lin K, Shi C, Pham T, Bisaria N, Kelley G . The biochemical basis of microRNA targeting efficacy. Science. 2019; 366(6472). PMC: 7051167. DOI: 10.1126/science.aav1741. View

10.

Yue B, Sun B, Liu C, Zhao S, Zhang D, Yu F . Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer. Cancer Sci. 2015; 106(10):1323-32. PMC: 4638023. DOI: 10.1111/cas.12759. View

11.

Fu X, Mao X, Chen Y, You N, Song Y, Zhang L . The Feasibility of Applying Artificial Intelligence to Gastrointestinal Endoscopy to Improve the Detection Rate of Early Gastric Cancer Screening. Front Med (Lausanne). 2022; 9:886853. PMC: 9150174. DOI: 10.3389/fmed.2022.886853. View

12.

Zang W, Hu Y, Qian C, Feng Y, Liu J, Yang J . HDAC4 promotes the growth and metastasis of gastric cancer via autophagic degradation of MEKK3. Br J Cancer. 2022; 127(2):237-248. PMC: 9296555. DOI: 10.1038/s41416-022-01805-7. View

13.

Zhao X, Xia X, Wang X, Bai M, Zhan D, Shu K . Deep Learning-Based Protein Features Predict Overall Survival and Chemotherapy Benefit in Gastric Cancer. Front Oncol. 2022; 12:847706. PMC: 9148960. DOI: 10.3389/fonc.2022.847706. View

14.

Papamichalis P, Zachou K, Papamichali R, Ioannou M, Gatselis N, Dalekos G . Promyelocytic Leukemia Antigen Expression: a Histological Marker for Primary Biliary Cholangitis Diagnosis?. J Transl Int Med. 2021; 9(1):43-51. PMC: 8016348. DOI: 10.2478/jtim-2021-0008. View

15.

Ouyang J, Xie Z, Lei X, Tang G, Gan R, Yang X . Clinical crosstalk between microRNAs and gastric cancer (Review). Int J Oncol. 2021; 58(4). PMC: 7895535. DOI: 10.3892/ijo.2021.5187. View

16.

Chang X, Ge X, Zhang Y, Xue X . The current management and biomarkers of immunotherapy in advanced gastric cancer. Medicine (Baltimore). 2022; 101(21):e29304. PMC: 9276259. DOI: 10.1097/MD.0000000000029304. View

17.

Chen J, Wang Y, Zhang X, Lv J, Li Y, Liu X . H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer. Neoplasma. 2016; 63(2):223-30. DOI: 10.4149/207_150821N454. View

18.

Lee K, Van Cutsem E, Bang Y, Fuchs C, Kudaba I, Garrido M . Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study. Clin Cancer Res. 2022; 28(16):3489-3498. DOI: 10.1158/1078-0432.CCR-22-0121. View

19.

Mohamed A, Omar A, R El-Awady R, Hassan S, Eitah W, Ahmed R . MiR-155 and MiR-665 Role as Potential Non-invasive Biomarkers for Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection. J Transl Int Med. 2020; 8(1):32-40. PMC: 7227164. DOI: 10.2478/jtim-2020-0006. View

20.

Casamayor M, Morlock R, Maeda H, Ajani J . Targeted literature review of the global burden of gastric cancer. Ecancermedicalscience. 2019; 12:883. PMC: 6345079. DOI: 10.3332/ecancer.2018.883. View